154 related articles for article (PubMed ID: 20698986)
1. Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro.
Liu JW; Cai MX; Xin Y; Wu QS; Ma J; Yang P; Xie HY; Huang DS
J Exp Clin Cancer Res; 2010 Aug; 29(1):108. PubMed ID: 20698986
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
Yip-Schneider MT; Nakshatri H; Sweeney CJ; Marshall MS; Wiebke EA; Schmidt CM
Mol Cancer Ther; 2005 Apr; 4(4):587-94. PubMed ID: 15827332
[TBL] [Abstract][Full Text] [Related]
3. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
4. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
5. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
6. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
Fang LJ; Shao XT; Wang S; Lu GH; Xu T; Zhou JY
Planta Med; 2010 Feb; 76(3):258-64. PubMed ID: 19774508
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide enhances dacarbazine activity against melanoma cells.
Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
[TBL] [Abstract][Full Text] [Related]
8. Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
Kim SL; Kim SH; Park YR; Liu YC; Kim EM; Jeong HJ; Kim YN; Seo SY; Kim IH; Lee SO; Lee ST; Kim SW
Mol Cancer Res; 2017 Feb; 15(2):141-151. PubMed ID: 28108625
[TBL] [Abstract][Full Text] [Related]
9. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.
Chen Y; Yu G; Yu D; Zhu M
J Exp Clin Cancer Res; 2010 Aug; 29(1):104. PubMed ID: 20684793
[TBL] [Abstract][Full Text] [Related]
10. Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.
Yeo AT; Porco JA; Gilmore TD
Cancer Lett; 2012 May; 318(1):53-60. PubMed ID: 22155272
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide-induced apoptosis, autophagy and suppression of proliferation in HepG2 cells.
Sun J; Zhang C; Bao YL; Wu Y; Chen ZL; Yu CL; Huang YX; Sun Y; Zheng LH; Wang X; Li YX
Asian Pac J Cancer Prev; 2014; 15(12):4897-902. PubMed ID: 24998560
[TBL] [Abstract][Full Text] [Related]
12. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
13. Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells.
Ghorbani-Abdi-Saedabad A; Hanafi-Bojd MY; Parsamanesh N; Tayarani-Najaran Z; Mollaei H; Hoshyar R
Mol Biol Rep; 2020 Aug; 47(8):5807-5815. PubMed ID: 32686017
[TBL] [Abstract][Full Text] [Related]
14. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
[TBL] [Abstract][Full Text] [Related]
15. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
16. Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9.
Yao H; Tang X; Shao X; Feng L; Wu N; Yao K
Cell Res; 2007 Jun; 17(6):565-71. PubMed ID: 17339884
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by parthenolide in human oral cancer cell lines and tumor xenografts.
Yu HJ; Jung JY; Jeong JH; Cho SD; Lee JS
Oral Oncol; 2015 Jun; 51(6):602-9. PubMed ID: 25817195
[TBL] [Abstract][Full Text] [Related]
18. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.
Shen Y; Cai M; Xia W; Liu J; Zhang Q; Xie H; Wang C; Wang X; Zheng S
Cancer Lett; 2007 Sep; 254(2):288-97. PubMed ID: 17462818
[TBL] [Abstract][Full Text] [Related]
19. Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression.
Talib WH; Al Kury LT
Biomed Pharmacother; 2018 Nov; 107():1488-1495. PubMed ID: 30257366
[TBL] [Abstract][Full Text] [Related]
20. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
Wang Z; Zhang Y; Banerjee S; Li Y; Sarkar FH
Cancer; 2006 Jun; 106(11):2503-13. PubMed ID: 16628653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
